Venus Concept Inc. Appoints Dr. Hemanth Varghese as President and Chief Operating Officer and Industry Veteran to Lead International Operations
October 12 2023 - 7:30AM
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ:
VERO), a global medical aesthetic technology leader, today
announced the promotion of Dr. Hemanth Varghese to the newly
created role of President and Chief Operating Officer (COO),
reporting to Chief Executive Officer, Rajiv De Silva, effective
October 16, 2023.
Dr. Varghese joined Venus Concept in October of
2022 as President and Chief Business Officer. His responsibilities
were later expanded to include the Chief Innovation Officer role as
well. Dr. Varghese has been pivotal in developing and executing the
Company’s turnaround strategy. In his new role, Dr. Varghese will
assume global oversight of Sales and Marketing, and Technical
Operations in addition to his ongoing responsibility for Corporate
Development, R&D, and Clinical Affairs. Ross Portaro, Executive
Vice President and General Manager, Global Sales and Marketing, as
well as William McGrail, Senior Vice President, Technical
Operations and Compliance, will be reporting to Dr. Varghese
directly.
“I am delighted to have Hemanth as our new
President & Chief Operating Officer, who will continue to build
on our strong achievements to date with our new company strategy,”
said Rajiv De Silva, Chief Executive Officer of Venus Concept. “His
past success and experience in driving business transformations and
high-level corporate strategy development coupled with the progress
he has made at Venus Concept over the last year, positions him well
to lead our key operational business functions and execute this
next phase of our strategic plan.”
Venus Concept also announced that Mr. Kirk
Gunhus has joined the Company as Vice President & General
Manager, International Sales and Marketing. Mr. Gunhus will report
directly to Ross Portaro and will be responsible for leading all
commercial operations in the Company’s direct international markets
and managing its global distribution partner network.
Mr. Gunhus is a seasoned aesthetics industry
professional with over 20 years of experience leading commercial
organizations in international markets with experience at companies
such as Medicis, Zeltiq, Sientra and MiraDry. “We are excited to
have Kirk’s leadership experience and successful track record in
driving commercial performance in high-growth markets around the
globe,” said Ross Portaro. “As we continue to reshape our
international footprint, Kirk’s deep industry knowledge and
experience in expanding international partner networks will be an
important driver of future growth in the business.”
About Venus Concept
Venus Concept is an innovative global medical
aesthetic technology leader with a broad product portfolio of
minimally invasive and non-invasive medical aesthetic and hair
restoration technologies and reach in over 60 countries and 14
direct markets. Venus Concept’s product portfolio consists of
aesthetic device platforms, including Venus Versa, Venus Legacy,
Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss,
Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Venus
Concept’s hair restoration systems include NeoGraft® and the ARTAS
iX® Robotic Hair Restoration system. Venus Concept has been backed
by leading healthcare industry growth equity investors including EW
Healthcare Partners (formerly Essex Woodlands), HealthQuest
Capital, Longitude Capital Management, Aperture Venture Partners,
and Masters Special Situations.
Investor Relations Contact:
ICR Westwicke on behalf of Venus Concept:
Mike Piccinino, CFA
VenusConceptIR@westwicke.com
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Aug 2023 to Aug 2024